Pricing Log in Create free account

Allarity Therapeutics, Inc. (ALLR) vs Context Therapeutics Inc. (CNTX)

Allarity Therapeutics, Inc. and Context Therapeutics Inc. are both Biotechnology companies. Context Therapeutics Inc. is the larger, with a market value of $17.3M against $15.5M — 1.1× the size. Across the 10 metrics below, Allarity Therapeutics, Inc. leads on 5 and Context Therapeutics Inc. on 5.

Valuation

Metric ALLR CNTX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 4.32 0.47 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.82 0.51 0.66
EV/Sales n/m n/m 9.02
Earnings yield (81.25%) (252.63%) (32.88%)
Free cash flow yield (92.18%) (188.15%) (23.13%)

Profitability

Metric ALLR CNTX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (157.09%) (76.14%) (51.96%)
Return on assets (46.26%) (68.96%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALLR CNTX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 95.02% 17.39% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALLR CNTX Biotechnology median
Debt to equity 0.40 0.00 0.00
Current ratio 1.11 5.81 4.97
Net debt to EBITDA 1.05 1.66 1.01

Dividend

Metric ALLR CNTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALLR CNTX Biotechnology median
Market cap 15.52m 17.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack